Publications in collaboration with researchers from Hospital Universitario de Salamanca (25)

2024

  1. Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers

    British Journal of Surgery, Vol. 111, Núm. 3

2022

  1. Dysregulated Expression of Three Genes in Colorectal Cancer Stratifies Patients into Three Risk Groups

    Cancers, Vol. 14, Núm. 17

  2. Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the PETHEMA/Spanish Myeloma Group (GEM)

    Leukemia and Lymphoma, Vol. 63, Núm. 14, pp. 3438-3447

2021

  1. Cohort profile: The Spanish Early-onset Colorectal Cancer (SECOC) cohort: A multicentre cohort study on the molecular basis of colorectal cancer among young individuals in Spain

    BMJ Open, Vol. 11, Núm. 12

  2. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

    Trials, Vol. 22, Núm. 1

  3. Endoluminal tumor implant of a colorectal cancer in an anal fistula detected by FISH techniques: A case report

    Journal of Gastrointestinal Oncology, Vol. 12, Núm. 2, pp. 900-905

  4. High-risk clinicopathological and genetic features and outcomes in patients receiving neoadjuvant radiochemotherapy for locally advanced rectal cancer

    Cancers, Vol. 13, Núm. 13

  5. Tracking the antibody immunome in sporadic colorectal cancer by using antigen self-assembled protein arrays

    Cancers, Vol. 13, Núm. 11

2020

  1. Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant recipients: Study protocol for the prospective multicentre OptimBioma study

    BMJ Open, Vol. 10, Núm. 7

  2. Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)

    Frontiers in Immunology

  3. Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus

    Frontiers in Immunology, Vol. 10, Núm. JUN

  2. VRK1 functional insufficiency due to alterations in protein stability or kinase activity of human VRK1 pathogenic variants implicated in neuromotor syndromes

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Combined assessment of the TNM stage and BRAF mutational status at diagnosis in sporadic colorectal cancer patients

    Oncotarget, Vol. 9, Núm. 35, pp. 24081-24096

  2. Generation and characterization of antibodies against opioid receptors from zebrafish

    International Journal of Molecular Sciences, Vol. 19, Núm. 1

2017

  1. Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors

    Oncotarget, Vol. 8, Núm. 64, pp. 107685-107700

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Genomic characterization of liver metastases from colorectal cancer patients

    Oncotarget, Vol. 7, Núm. 45, pp. 72908-72922

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2014

  1. Association between the cytogenetic profile of tumor cells and response to preoperative radiochemotherapy in locally advanced rectal cancer

    Medicine (United States), Vol. 93, Núm. 26